Diamond Publications - Search Results

Search Again...

These results include publications that have not yet been reviewed and processed by Diamond Light Source. To view only processed publications click here.

You can use the folder icon under Actions to collate papers as required. You can then click on View Folder in the left-hand navigation to review and/or download your folder.

One item found (0 items not approved).

Instruments / Technical Area	Publication Details	Published	Actions
I03-Macromolecular Crystallography	A high-throughput screening triage workflow to authenticate a novel series of PFKFB3 inhibitors Stephen A. St-Gallay , Neil Bennett , Susan E. Critchlow , Nicola Curtis , Gareth Davies , Judit Debreczeni , Nicola Evans , Ian Hardern , Geoff Holdgate , Neil P. Jones , Lindsey Leach , Sarita Maman , Sheila Mcloughlin , Marian Preston , Laurent Rigoreau , Andrew Thomas , Andrew P. Turnbull , Graeme Walker , Jarrod Walsh , Richard A. Ward , Ed Wheatley , Jon Winter-Holt Slas Discovery: Advancing Life Sciences R&d 27 DOI: 10.1177/2472555217732289 Diamond Proposal Number(s): [5735] Show Abstract ▼ Abstract: A high-throughput screen (HTS) of human 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) resulted in several series of compounds with the potential for further optimization. Informatics was used to identify active chemotypes with lead-like profiles and remove compounds that commonly occurred as actives in other HTS screens. The activities were confirmed with IC50 measurements from two orthogonal assay technologies, and further analysis of the Hill slopes and comparison of the ratio of IC50 values at 10 times the enzyme concentration were used to identify artifact compounds. Several series of compounds were rejected as they had both high slopes and poor ratios. A small number of compounds representing the different leading series were assessed using isothermal titration calorimetry, and the X-ray crystal structure of the complex with PFKFB3 was solved. The orthogonal assay technology and isothermal calorimetry were demonstrated to be unreliable in identifying false-positive compounds in this case. Presented here is the discovery of the dihydropyrrolopyrimidinone series of compounds as active and novel inhibitors of PFKFB3, shown by X-ray crystallography to bind to the adenosine triphosphate site. The crystal structures of this series also reveal it is possible to flip the binding mode of the compounds, and the alternative orientation can be driven by a sigma-hole interaction between an aromatic chlorine atom and a backbone carbonyl oxygen. These novel inhibitors will enable studies to explore the role of PFKFB3 in driving the glycolytic phenotype of tumors.	Sep 2017

Instruments / Technical Area

Publication Details

Published

Actions

I03-Macromolecular Crystallography

A high-throughput screening triage workflow to authenticate a novel series of PFKFB3 inhibitors